Development of High-content Assays for Compound Screening and Hit Validation
Kamyar Hadian, Helmholtz Zentrum Munchen, speaking at Hight Content Analysis 2014
Advanced Molecular Tools for Proteome Analyses
Masood Kamali-Moghaddam, Uppsala University, speaking at Advances ibn qPCR and dPCR 2014
High Content Screening for Target and Pathway Analysis in Cell Based Assays
Eugenio Fava, Deutsches Zentrum für Neurodegenerative Erkrankungen, speaking at High Content Analysis 2014.
Analysis of Gene and microRNA Function through High-Content Screening
Miguel Mano, ICGEB Trieste, speaking at High Content Analysis 2014
Automated Injection of Cancer Cells in 3D ECM Scaffolds and Zebrafish Embryos for (Personalized) Compound Screening
Jan De Sonneville, Life Science Methods B.V, speaking at High Content Analysis 2014
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart
Advances in Volatile Analyses for Disease Diagnosis
Norman Ratcliffe, University of the West of England, speaking at Advances in Biodetection & Biosensors 2014.
Worried about your cell-based assays? Remote monitoring with CNS offers complete peace of mind!
Michael Fejtl, Market Manager, Tecan Austria
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches
Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe